Clinical Trials Logo

Prostate Hyperplasia clinical trials

View clinical trials related to Prostate Hyperplasia.

Filter by:

NCT ID: NCT05017285 Not yet recruiting - Clinical trials for Prostate Hyperplasia

Ejaculation Preservation After Laser Enucleation Prostate

EPALEP
Start date: September 2021
Phase: N/A
Study type: Interventional

A multicentre randomised controlled trial evaluating the benefit of median lobe preservation on the incidence of retrograde ejaculation during prostate enucleation by HoLEP.

NCT ID: NCT04848181 Completed - Clinical trials for Prostate Hyperplasia

The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate

Start date: July 1, 2019
Phase: Early Phase 1
Study type: Interventional

Perioperative bleeding is the most common complication related to transurethral resection of prostate, the aim of the study is to compare the effect of pre-operative use of finasteride versus Cyproterone acetate on blood loss with mono polar TURP

NCT ID: NCT04781985 Completed - Clinical trials for Prostate Hyperplasia

Prostatic Resection Cavity Stone Post Transurethral Resection of the Prostate (TURP). A Rare Case Scenario

prostatic
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Prostatic resection cavity stone post transurethral resection of the prostate (TURP). A rare case scenario

NCT ID: NCT04781049 Completed - Clinical trials for Benign Prostatic Hyperplasia

Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The primary objective of the study is to compare Trans-Perineal Laser Ablation of Prostate versus Trans-Urethral Resection of Prostate in the immediate impact on post-operative pain; in terms of relief in benign prostatic obstruction and preservation of the ejaculatory function in the short term (at 1, 3 and 6 months). The secondary objective of the study is the evaluation of the long-term deobstructive effectiveness (12 months).

NCT ID: NCT04580628 Completed - Clinical trials for Prostate Hyperplasia

Thuflep/SOLEP : Initial Experience and Results of Prostate Laser Enucleation With Thulium-fiber Laser (TFL)

Start date: July 1, 2020
Phase:
Study type: Observational

Thuflep TLF: initial experience and results of prostate laser enucleation with fibrous thulium laser (TLF)

NCT ID: NCT04514718 Not yet recruiting - Quality of Life Clinical Trials

Low Energy HoLEP on IPSS

Start date: August 24, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to prove that low-energy (30W) Holmium laser prostatectomy (Holeb) is not inferior to high-energy (100W) Holmium laser prostatectomy (safety and effectiveness)

NCT ID: NCT04288427 Recruiting - Clinical trials for Benign Prostatic Hyperplasia

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Start date: September 25, 2020
Phase: N/A
Study type: Interventional

The study is being conducted to learn why some patients with Benign Prostatic Hyperplasia (BPH) do not respond to a commonly used treatment drug, Finasteride. The hope is to find ways to predict which patients will not respond to Finasteride so that, in the future, these patients can be identified prior to offering this treatment and they can be offered alternative treatment strategies in its place. The aim is to see if noninvasive techniques such as MRI can detect inflammation of the prostate to assist with early detection of those who will and who will not respond to Finasteride.

NCT ID: NCT04275076 Completed - Clinical trials for Prostate Hyperplasia

HoLEP Vs BPEP for Large Prostatic Adenoma

enucleation
Start date: February 1, 2018
Phase: Phase 3
Study type: Interventional

Benign prostatic hyperplasia (BPH) is one of the most common urinary disorders in elderly males. The symptoms of BPH include impaired physiological and functional well-being, which interferes with daily living. At present, transurethral resection of the prostate (TURP) is the standard surgical treatment. However, the high rate of complications associated with TURP is a major drawback of this procedure. Holmium laser enucleation of the prostate (HoLEP) was proven to be an effective surgical treatment for BPH with no prostate size limitation with adequate hemostasis, bipolar enucleation of the prostate (BPEP) has been introduced as an alternative energy source with a promising outcome with equal safety and efficacy

NCT ID: NCT04212403 Completed - Bladder Cancer Clinical Trials

Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)

Prophylaxis001
Start date: September 17, 2018
Phase: N/A
Study type: Interventional

To investigate the use of antibiotic prophylaxis in patients undergoing TURP and TURB. The investigators set up a prospective, randomized controlled trial in which (after exclusion of risk factors) patients will be randomized in receiving levofloxacin (Tavanic) orally or no antibiotics. The exclusion criteria for TURP are a pre-operative transurethral catheter or > 100 urinary white blood cells in the pre-operative urine sample. The exclusion criteria for TURB are a pre-op catheter or clinical signs of infection.

NCT ID: NCT03966950 Recruiting - Clinical trials for Postoperative Complications

Use of Melatonin for Preventing POCD in Transurethral Prostate Resection Under Spinal Anesthesia

Start date: June 26, 2017
Phase: N/A
Study type: Interventional

This study aims to evaluate the possible effect of melatonin on prevention of cognitive dysfunction in the postoperative period of elderly patients undergoing transurethral resection of the prostate (TURP) under spinal anesthesia